Market Place
Sourcing Support
Egis` medicines won the Innovation Grand Prize
26 Mar 2024 //
PRESS RELEASE
This Year Marks The 110th Anniversary Of Our Company`s Foundation
09 Jan 2024 //
PRESS RELEASE
Hungarian Pharmaceutical Company Debuts New Services in Barcelona
25 Oct 2023 //
HUNGARY TODAY
Egis expands its portfolio with active pharmaceutical ingredient contract development and contract manufacturing
24 Oct 2023 //
PRESS RELEASE
Suprastin Becomes Georgian Consumers’ Favorite Allergy Remedy
25 Jun 2023 //
FINCHANNEL
Egis sponsored the 40th Hungarian Press Photo Contest
04 May 2022 //
PRESS RELEASE
Egis Pharma has relocated its main offices at One Tower building
25 Jan 2022 //
BUSINESS REVIEW
Egis Favipiravir Drug Licenced for Covid-19 Treatment
20 Dec 2021 //
HUNGARYTODAY
Crescita Signs Exclusive 8-Country Licensing Agreement with Egis Pharma
13 Dec 2021 //
BUSINESSWIRE
Egis Group to invest €50 million in India over the next five years
11 Nov 2021 //
ECONOMIC TIMES
Genedata has Successfully Collaborated with Egis Pharmaceuticals PLC
12 Oct 2021 //
PRESS RELEASE
Egis Pharma Registers First Blood-based CE IVD Precision Medicine Tool
16 Mar 2021 //
MEDINDIA
French firm Egis plans €75-m investment in India in five years
27 Feb 2021 //
FINANCIAL EXPRESS
Strategic cooperation agreement between Semmelweis University and Egis
13 Feb 2020 //
PRESS RELEASE
EPSA Autumn Assembly under the general sponsorship of JGL
03 Nov 2019 //
PRESS RELEASE
Egis Pharmaceuticals to launch Mundipharma’s Pelmeg in CEE markets
14 Jun 2019 //
PHARMACEUTICAL-TECHNOLOGY
Steep discounts help biotech drug copies gain ground in Europe
23 Sep 2015 //
REUTERS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.